Abstract: An automotive front seat overhead airbag includes a supporting air chamber and a protective air chamber mounted on a roof. The supporting air chamber is inflated from the roof towards a dashboard upon inflation. The protective air chamber is in communication with the supporting air chamber. After the supporting air chamber is inflated, the protective air chamber is inflated from the supporting air chamber towards the human body. A first protective space is reserved between the supporting air chamber and the protective air chamber on a side facing the human body. The first protective space corresponds to the head of the human body for protecting the head and neck of the human body. An automobile includes a roof and a dashboard, and further includes the automotive front seat overhead airbag described above. An upper end of the supporting air chamber is connected to a gas generator.

Abstract: An electronic device and communication method are disclosed. The electronic device comprises a processing circuit configured to perform a pre-processing operation on a first one-dimensional sequence of modulation symbols, the pre-processing operation including: performing a dimension-increasing conversion to convert the first one-dimensional sequence of modulation symbols into a first multi-dimensional modulation symbol block; transforming the first multi-dimensional modulation symbol block into a second multi-dimensional modulation symbol block with a first transformation, wherein the first transformation couples each symbol in the first multi-dimensional modulation symbol block with each other; and performing a dimension-decreasing conversion to convert the second multi-dimensional modulation symbol block into a second one-dimensional sequence of modulation symbols, wherein the dimension-decreasing conversion is an inverse process of the dimension-increasing conversion.

Abstract: The present disclosure relates to electronic device, method for wireless communication system and storage medium. The present disclosure proposes an electronic device on a control device side for a wireless communication system, comprising: a processing circuit configured to group a plurality of terminal devices of the wireless communication system into one linear precoding terminal device group and one or more nonlinear precoding terminal device groups based on respective nonlinear precoding capabilities and channel state information of the plurality of terminal devices; and notify each terminal device whether nonlinear precoding or linear precoding is to be employed in communication for the terminal device by means of a nonlinear precoding indicator based on the grouping.

Abstract: The present invention provides compounds of Formula I which can be used as macrophage migration inhibitory factor (MIF) inhibitors; methods for the production of the compounds of the invention; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by MIF by administering the compounds of the invention.

Abstract: This application provides a narrowband interference isolation method and a communication apparatus. An example method includes: determining a parameter of a narrowband interference signal; determining a coefficient of a first filter based on the parameter of the narrowband interference signal, wherein the first filter is located at a receive end of a master communication device, and the coefficient of the first filter is for filtering out the narrowband interference signal; and sending the parameter of the narrowband interference signal or the coefficient of the first filter to M slave communication devices using an Ethernet operation, administration, and maintenance (OAM) frame, wherein the master communication device is connected to the M slave communication devices, M?1, and M is an integer.

Abstract: A speaker module and a headset (100) are provided. The speaker module is used for the headset (100). The headset (100) includes a housing (1). The speaker module includes a first speaker unit (4a) and a second speaker unit (4b). An outer surface of a first diaphragm assembly (4a21) of the first speaker unit (4a) faces a first side, the second speaker unit (4b) is located on one side of a circumferential direction of the first speaker unit (4a), the second speaker unit (4b) emits sound toward the first side, and sound emission frequency of the second speaker unit (4b) is greater than sound emission frequency of the first speaker unit (4a).

Abstract: Disclosed are a hybrid system and method of waste heat utilization-based photovoltaic power generation and seawater desalination, wherein a photovoltaic power generation unit includes a linear Fresnel lens, a beam-splitting cooling tube, a solar cell, and a heat collecting tube; a seawater supply unit includes a seawater storage tank and a pre-treatment storage tank; a heat storage and temperature control unit includes a phase-change heat reservoir and heat exchangers; an electrodialysis unit includes poles, an ion-selective membrane, a desalination chamber, a concentration chamber, pole chambers, a concentrated liquid storage tank and a desalinated liquid storage tank; and an electricity storage and control unit includes a battery pack and a circuit controller. Incident sunlight achieves photovoltaic power generation by a light condensation followed by beam splitting mode; nanoparticle doped seawater absorbs long-wavelength light and transmits short-wavelength light.

Abstract: Narrow bandgap n-type small molecules are attracting attention in the near-infrared organic optoelectronics field, due to their easy tunable energy band with a molecular design flexibility. However, only a few reports demonstrate narrow bandgap non-fullerene acceptors (NFAs) that perform well in organic solar cells (OSCs), and the corresponding benefits of NFA photodiodes have not been well investigated in organic photodetectors (OPDs). Here, the ultra-narrow bandgap NFAs CO1-4F, CO1-4Cl and o-IO1 were designed and synthesized for the achieved efficient near-infrared organic photodiodes such as solar cells and photodetectors. Designing an asymmetrical CO1-4F by introducing two different ?-bridges including alkylthienyl and alkoxythienyl units ultimately provides an asymmetric A-D?-D-D?-A molecular configuration. This enables a delicate modulation in energy band structure as well as maintains an intense intramolecular charge transfer characteristic of the excited state.

Abstract: The present invention provides compounds of Formula I which can be used as macrophage migration inhibitory factor (MIF) inhibitors; methods for the production of the compounds of the invention; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by MIF by administering the compounds of the invention.

Abstract: Provided is an amide oxazole compound, in particular a compound, as represented by formula (IV), or a pharmaceutically acceptable salt thereof.

Abstract: Disclosed is a method for preparing a chlorinated compound, and specifically disclosed is a method for preparing a compound represented by formula (I).

Abstract: The present invention provides compounds of Formula (I) which can be used as CCR8 inhibitors, which can be used as treatment or prevention of cancer using CCR8 inhibitors targeted tumor specific T regulatory cells.

Abstract: Provided are a crystal of a compound of formula (I), salt thereof, a crystal of the salt thereof, and a preparation method for the crystal. Also comprised are applications of the compound and the crystal in preparation of drugs for treating IRAK4-related diseases.

Abstract: The present invention provides compounds of Formula (I) which can be used as CCR8 inhibitors, which can be used as treatment or prevention of cancer using CCR8 inhibitors targeted tumor specific T regulatory cells.

Abstract: Disclosed are a class of compounds having a highly selective inhibition of ROS1, and the use thereof in the preparation of drugs for treating diseases related to abnormal ROS1 kinase expression. Specifically disclosed are compounds represented by formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides ROR1 specific chimeric antigen receptors (CAR) and their therapeutic use. The CAR comprises a signal peptide, a ROR1 antigen binding domain, a hinge, a transmembrane domain, a co-stimulatory domain and an intracellular signaling domain. The modified immune cells endowed with such CARs are suitable for treating malignancies such as cancer, chronic lymphocyte leukemia (CLL), and acute lymphocytic leukemia (ALL).

Abstract: The present invention relates to anti-ROR1 antibodies and to methods of using anti-ROR1 antibodies. The anti-ROR1 antibodies described herein are useful for the diagnosis and treatment of diseases, such as various cancers, associated with aberrant expression of ROR1.

Abstract: A compound of formula (II), a tautomer thereof or a pharmaceutically acceptable salt thereof, and use thereof in the preparation of medicaments for treating solid tumor-related diseases.

Abstract: Disclosed in the present invention are an IRAK4 inhibitor, and an application thereof in preparation of a drug for treating IRAK4-related diseases. Specifically disclosed are a compound represented by formula (III) and a pharmaceutically acceptable salt thereof.